Buys
Open market- Shares
- Avg price
- Total value
Linda C. Burkly - EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc.
Issuer-level insider activity
- Role
- Evp, Chief Scientific Officer
- Issuer ticker
- EDIT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Linda C. Burkly in Editas Medicine, Inc.
Sells
Open market- Shares
- -7,831
- Avg price
- $2.56
- Total value
- -$20,023
Net
Past year- Shares
- -7,831
- Share %
- -100%
- Total value
- -$20,023
Reported holdings for Linda C. Burkly in Editas Medicine, Inc.
Form 4 holding
EVP, CHIEF SCIENTIFIC OFFICER
Editas Medicine, Inc.
- Security class
- Common Stock
- Shares / value
- 62,369
- Estimated value
- $166,525
- Report date
- 28 Jul 2026
- Price
- $2.67
- Ownership
- Direct
Form 4 holding
EVP, CHIEF SCIENTIFIC OFFICER
Editas Medicine, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 292,856
- Estimated value
- Report date
- 12 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Linda C. Burkly in Editas Medicine, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.